Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Quest Diagnostics Inc (DGX)  
$137.55 0.63 (0.46%) as of 4:30 Wed 5/1


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 134,770,000
Market Cap: 18.54(B)
Last Volume: 676,634 Avg Vol: 1,177,221
52 Week Range: $120.62 - $144.92
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  724
Guru Rank Value     : 1.3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 16,337 16,337 16,337 534,469
Total Sell Value $2,062,619 $2,062,619 $2,062,619 $75,079,355
Total People Sold 3 3 3 6
Total Sell Transactions 6 6 6 24
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 787
  Page 2 of 32  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Deppe Michael J SVP, Corp. Controller & CAO   •       –      –    2024-02-23 4 A $125.02 $211,159 D/D 1,689 35,670     -
   Gregg Vicky B Director   –       •      –    2024-02-23 4 S $126.64 $316,597 D/D (2,500) 16,329 -9%     
   Doherty Catherine T. EVP, Regional Businesses   •       –      –    2024-02-22 4 AS $126.14 $103,561 D/D (821) 70,800 7%     
   Prevoznik Michael E SVP & General Counsel   •       –      –    2024-02-22 4 AS $126.14 $83,379 D/D (661) 40,206 7%     
   Deppe Michael J SVP, Corp. Controller & CAO   •       –      –    2024-02-21 4 D $125.02 $11,127 D/D (89) 33,981     -
   Kuppusamy Karthik SVP, Clinical Solutions   •       –      –    2024-02-21 4 D $125.02 $12,752 D/D (102) 13,977     -
   Doherty Catherine T. EVP, Regional Businesses   •       –      –    2024-02-21 4 D $125.02 $61,635 D/D (493) 71,621     -
   Prevoznik Michael E SVP & General Counsel   •       –      –    2024-02-21 4 D $125.02 $50,883 D/D (407) 40,867     -
   Davis J. E. CEO and President   •       •      –    2024-02-21 4 D $125.02 $95,265 D/D (762) 124,123     -
   Plewman Patrick SVP for Diagnostic Services   •       –      –    2024-02-21 4 D $125.02 $17,378 D/D (139) 14,896     -
   Delaney Mark E SVP & Chief Commercial Officer   •       –      –    2024-02-14 4 A $0.00 $0 D/D 2,348 5,828     -
   Samad Samer Abdul Executive Vice President & CFO   •       –      –    2024-02-14 4 A $0.00 $0 D/D 5,478 21,988     -
   Kuppusamy Karthik SVP, Clinical Solutions   •       –      –    2024-02-14 4 A $0.00 $0 D/D 2,641 14,079     -
   Plewman Patrick SVP for Diagnostic Services   •       –      –    2024-02-14 4 A $0.00 $0 D/D 2,446 15,035     -
   Gardner Mark A SVP of Molecular Gen & Oncol   •       –      –    2024-02-14 4 A $0.00 $0 D/D 2,250 5,055     -
   Deppe Michael J SVP, Corp. Controller & CAO   •       –      –    2024-02-14 4 A $0.00 $0 D/D 558 34,070     -
   Doherty Catherine T. SVP, Regional Businesses   •       –      –    2024-02-14 4 A $0.00 $0 D/D 4,304 72,114     -
   Prevoznik Michael E SVP & General Counsel   •       –      –    2024-02-14 4 A $0.00 $0 D/D 2,935 41,274     -
   Davis J. E. CEO and President   •       •      –    2024-02-14 4 A $0.00 $0 D/D 22,251 124,885     -
   Plewman Patrick SVP for Diagnostic Services   •       –      –    2024-01-31 4 A $129.33 $6,466 D/D 50 12,589     -
   Kuppusamy Karthik SVP, Clinical Solutions   •       –      –    2024-01-31 4 A $129.33 $3,750 D/D 29 11,438     -
   Samad Samer Abdul Executive Vice President & CFO   •       –      –    2024-01-31 4 A $129.33 $2,199 D/D 17 16,510     -
   Gregg Vicky B Director   –       •      –    2024-01-31 4 A $129.33 $11,381 D/D 88 18,829     -
   Gregg Vicky B Director   –       •      –    2023-10-23 4 A $122.86 $11,303 D/D 92 18,741     -
   Kuppusamy Karthik SVP, Clinical Solutions   •       –      –    2023-10-23 4 A $122.86 $3,686 D/D 30 11,358     -
  787 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 32
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us